Cancer & tumour markers PSA (prostate), CA125 (ovarian) and other markers for early detection
-25% NOW Omega 3 Fish Oil 1000 mg / 30 Softgels 5.37 / 10.50
Backed up by science
Semaglutide is prescribed for: Weight loss in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) Weight loss in adult patients with an initial body mass index (BMI) of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (hypertension, type 2 diabetes mellitus, or dyslipidemia) Weight loss in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity) Reducing the risk of major adverse cardiovascular events (non-fatal myocardial infarction, CV death, or non-fatal stroke) in adults with cardiovascular disease and either obesity or overweight Treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis (stages F2 to F3 fibrosis) in adults Patients taking semaglutide for any of these conditions, especially weight loss, are typically suggested to maintain a low-carb and low-fat diet
In addition, muscle mitochondrial DNA deletions have been reported in patients with migraine, marking the first instance of mitochondrial DNA deletion linked to migraine
Trazodone is also a 3A4 substrate, and so giving it with 3A4 inhibitors can heighten and prolong the sedation
